RARA CRAFT DATABASE for FDA Medical Devices
510(k)K172019

FDA DEVICE FACTS

Brisbane ALIF Device, Gladstone ALIF Device

Signature Orthopaedics Pty, Ltd.

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATENovember 29, 2017PRODUCT CODEOVD

Indications for use

The Signature Orthopaedics Brisbane ALIF and Gladstone ALIF systems are indicated for use with autogenous bone graft in patients with degenerative disc disease (DDD) at one or two contiguous levels from L2 to S1. These DDD patients may also have up to Grade I spondylolisthesis or retrolisthesis at the involved levels. DDD is defined as discogenic back pain with degeneration of the disc confirmed by history and radiographic studies. These patients should be skeletally mature and have had six months of non-operative treatment. Patients with previous non-fusion spinal surgery at the treated level may be treated. These implants may be implanted via a laparoscopic or an open anterior approach. The Brisbane and Gladstone ALIF systems may be used as stand-alone devices or in conjunction with supplemental fixation. When used as a stand-alone device the subject devices must be used with all three screws. Performance Testing: Non-clinical testing and engineering evaluations were conducted to verify that the performance of the Brisbane ALIF and Gladstone ALIF cages are adequate for anticipated in-vivo use. Non-clinical testings carried out on the worst case of the two systems as identified Finite Element Analysis (FEA) were:

• Static and dynamic compression and compression shear testing per ASTM-F2077

• Subsidence testing ASTM-F2267

• Screw insertion testing per ASTM-F543

• Screw pull-out testing per ASTM-F543

• Screw torque to failure testing per ASTM-F543 Also the coating on the Brisbane ALIF cage has undergone the following testings:

• Powder Chemistry per ASTM-F1580

• Coating Chemistry per ASTM-F1580

• Coating Thickness per ASTM-F1854-09

• Percent Porosity per ASTM-F1854-09

• Coating Roughness per ASTM-F854-09

• Static Shear per ASTM-F1044-05

• Static Tensile per ASTM-F1147-05

• Shear Fatigue per ASTM-F1160-05

• Abrasion per ASTM-F1978-00

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: August 28, 2026